A Study of Donanemab (LY3002813) in Healthy Participants
Clinical trial NCT05567159 · COMPLETED
Trial details
- NCT number
- NCT05567159
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-04
- Primary completion
- 2023-07-14
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.